HFpEF Calculator (H2FPEF Score)

HFpEF Calculator Guide: Understanding the H2FPEF Score, Clinical Use, and Next Steps

What is HFpEF?

Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome where patients have symptoms and signs of heart failure despite a left ventricular ejection fraction that is usually normal or near normal. Many patients present with exertional shortness of breath, fatigue, reduced exercise tolerance, lower extremity swelling, or repeated episodes of congestion. Unlike heart failure with reduced ejection fraction, HFpEF often reflects complex abnormalities involving ventricular relaxation, filling pressures, vascular stiffness, atrial function, pulmonary circulation, and systemic comorbidities.

HFpEF is especially common in older adults and in people with hypertension, obesity, diabetes, chronic kidney disease, atrial fibrillation, and metabolic syndrome. Because no single finding confirms HFpEF in every patient, diagnosis can be challenging and often requires a structured approach. That is where an HFpEF calculator based on the H2FPEF score can be useful.

Why use an HFpEF calculator?

An HFpEF calculator provides a practical method to estimate pretest probability in patients with unexplained dyspnea and suspected diastolic dysfunction. It helps clinicians and trainees quickly synthesize key bedside and echocardiographic data into a single score. A low score suggests alternative causes are more likely, while a high score supports further HFpEF-focused evaluation and management.

Using a scoring approach can improve consistency in diagnostic reasoning, support communication across teams, and clarify when advanced testing may be appropriate. It can also help patients understand why their physician recommends specific tests, such as detailed echocardiography, natriuretic peptide measurement, exercise testing, or invasive hemodynamic assessment in selected cases.

H2FPEF variables and scoring

The H2FPEF model includes six weighted domains that are commonly available in clinical practice:

• Heavy (BMI > 30 kg/m²): 2 points
• Hypertensive treatment (≥ 2 antihypertensive medications): 1 point
• Atrial fibrillation: 3 points
• Pulmonary hypertension (PASP > 35 mmHg): 1 point
• Elder age (> 60 years): 1 point
• Filling pressure (E/e′ > 9): 1 point

Total score ranges from 0 to 9. In general, higher scores are associated with higher probability of HFpEF. The score is particularly helpful in patients with dyspnea where differentiation from pulmonary disease, deconditioning, obesity-related limitation, or ischemic syndromes can be difficult.

How to use this HFpEF calculator accurately

For reliable output, use current and verified clinical data. Confirm atrial fibrillation status from ECG or documented rhythm history. Use a recent BMI based on measured height and weight, and verify medication count as active antihypertensive therapy rather than historical prescriptions. Ensure echocardiographic values such as E/e′ and pulmonary artery systolic pressure are measured according to quality standards and interpreted in context of image quality and loading conditions.

If one or more variables are uncertain, avoid over-interpreting the score. Repeat measurement or comprehensive echocardiography may be needed. Scoring tools are most useful when integrated with symptom burden, natriuretic peptides, chamber structure, diastolic parameters, pulmonary findings, kidney function, and volume status.

Interpreting low, intermediate, and high scores

Low score (0–1): HFpEF is less likely. Consider alternative explanations of dyspnea such as pulmonary disease, anemia, obesity hypoventilation, thyroid disease, deconditioning, ischemia, valvular disease, and medication effects. Reassess if symptoms progress or new objective evidence appears.

Intermediate score (2–5): Diagnostic uncertainty remains significant. This group often benefits from additional testing: natriuretic peptides, exercise diastolic stress echo, cardiopulmonary exercise testing, or targeted hemodynamic evaluation depending on local expertise and patient complexity.

High score (6–9): HFpEF is more likely. Clinical management should still be individualized and diagnosis confirmed through comprehensive evaluation. Comorbid conditions such as atrial fibrillation, obesity, hypertension, CKD, diabetes, and sleep-disordered breathing often drive symptoms and should be treated aggressively.

Limitations and clinical caveats

No calculator can replace full clinical judgment. The HFpEF calculator is not a stand-alone diagnostic test. Performance can vary across populations, referral settings, age groups, and levels of comorbidity. Certain patients may have normal resting values but abnormal exercise hemodynamics, while others may show elevated pressures for reasons not specific to HFpEF.

Potential limitations include measurement variability in E/e′ and PASP, rhythm-dependent changes, and confounding by pulmonary vascular disease or severe obesity. Borderline scores should prompt careful reassessment rather than definitive labeling. Clinicians should integrate all available data, including longitudinal symptom trends and response to therapy.

Recommended diagnostic workup when HFpEF is suspected

A practical workup often includes:

• Comprehensive history and focused cardiovascular and pulmonary examination
• 12-lead ECG and rhythm assessment for atrial fibrillation or conduction abnormalities
• Echocardiography with diastolic parameters, left atrial size, LV wall thickness, and estimated filling pressures
• Natriuretic peptides (BNP or NT-proBNP), interpreted in clinical context and body habitus
• Routine laboratory testing (renal function, hemoglobin, glucose, thyroid profile when indicated)
• Chest imaging and pulmonary evaluation when respiratory etiologies are possible
• Exercise testing or invasive hemodynamics in unresolved or complex cases

This structured approach reduces missed diagnoses and helps identify mixed pathology, which is common in real-world HFpEF presentations.

Management principles in suspected or confirmed HFpEF

HFpEF treatment focuses on symptom relief, decongestion, risk reduction, and management of comorbid disease. Diuretics are commonly used for fluid overload. Blood pressure control, rhythm or rate management in atrial fibrillation, glycemic optimization, kidney protection, and lifestyle intervention are central to outcomes. Weight reduction, physical activity, and management of sleep apnea can significantly improve functional status.

Pharmacologic strategies continue to evolve, and guideline-directed therapy should be tailored to individual profile, renal function, blood pressure, and frailty status. Multidisciplinary follow-up is often beneficial, particularly for patients with recurrent admissions, reduced exercise capacity, or complex multimorbidity.

Who can benefit from this page?

This HFpEF calculator resource is useful for clinicians, trainees, allied health professionals, and informed patients who want to understand the logic of HFpEF probability scoring. It can support bedside teaching, outpatient review, or preliminary triage discussions before specialist consultation. For patients, it provides context on why specific tests and follow-up plans are recommended.

Clinical safety reminder

Urgent symptoms such as chest pain, severe shortness of breath at rest, syncope, confusion, cyanosis, or rapidly worsening edema require immediate medical evaluation. Online tools should never delay emergency care.